LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
12.46
-0.24 (-1.89%)
At close: Jun 13, 2025, 4:00 PM
12.34
-0.12 (-0.96%)
After-hours: Jun 13, 2025, 6:56 PM EDT
LifeMD Market Cap
LifeMD has a market cap or net worth of $566.28 million as of June 13, 2025. Its market cap has increased by 72.33% in one year.
Market Cap
566.28M
Enterprise Value
556.98M
1-Year Change
72.33%
Ranking
Category
Stock Price
$12.46
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $566.28M, an increase of 16,079.35%. That is a compound annual growth rate of 51.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 577.20M | 169.22% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |